Company: NDRA
Filing Date: 2025-04-02
Form Type: S-8
Source: 0001654954-25-003848
Chunk: 3

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-04-02
Form: S-8
Chunk 3
---
 (File No. 333-214724) filed on December 6, 2016)          |
| 4.6            |     | Form of Restricted Stock Unit Award under ENDRA Life Sciences Inc. 2016 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.6 to Amendment No. 1 to the Registrant’s Registration Statement on Form S-1 (File No. 333-214724) filed on December 6, 2016) |
| 5.1*           |     | Opinion of K&L Gates LLP                                                                                                                                                                                                                                             |
| 23.1*          |     | Consent of RBSM LLP, Independent Registered Public Accounting Firm                                                                                                                                                                                                   |
| 23.2           |     | Consent of K&L Gates LLP (contained in Exhibit 5.1)                                                                                                                                                                                                                  |
| 24.1           |     | Power of Attorney (included on the signature page of this Registration Statement)                                                                                                                                                                                    |
| 107.1*         |     | Filing Fee Table                                                                                                                                                                                                                                                     |

* - Filed herewith

| 5 |

<div align='center'>SIGNATURES</div>

Pursuant to the requirements of the Securities Act, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Ann Arbor, State of Michigan, on April 2, 2025.

| ENDRA Life Sciences Inc. |                                |
| By:                      | /s/ Alexander Tokman           |
|                          | Alexander Tokman               |
|                          | Acting Chief Executive Officer |

| 6 |

<div align='center'>POWER OF ATTORNEY</div>

Each person whose signature appears below constitutes and appoints Alexander Tokman and Richard Jacroux, and each of them, his/her true and lawful attorney-in-fact and agent, each with full power of substitution and resubstitution, severally, for him/her and in his/her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement on Form S-8, and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full